Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
6 drugs in development
By Therapeutic Area
top 5
R&D Momentum
79/100
Pipeline Velocity
51/100
Trial Completion Rate
76/100
Pipeline Concentration
22/100
Pipeline Freshness
43/100
Strategic Signals
Activity
Last 14 days
The Role of a Postoperative Home Physical Therapy Program for the Treatment of Pelvic Pain in Patients Undergoing Endometriosis Excision
Effect of Chlorhexidine Perineal Lavage Following Defecation in Post-Menopausal Women With Recurrent Urinary Tract Infection
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Assessing the Use of Wearable Activity Trackers in a Pregnancy Cohort
Social Support During a Randomized Trial of a Trucker Weight Loss Intervention
Body and the Brain: Cortical Reactivity and Cognitive-Affective Regulation to Experimental Pain.
Efficacy of a Single-session Treatment for Reducing Chronic Pain Prior to Gender-affirming Surgery
Remote Mindfulness-Education Intervention for Women With Provoked Localized Vulvodynia: A Randomized Clinical Study
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)